Back to Top
Stapokibart Biosimilar - Research Grade
$710.00 - $19,500.00
Stapokibart Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
IL4R
Concentration
5mg/ml
Isotype
Human IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P24394
Shipping Conditions
Blue ice
Background
The IL-4 receptor alpha chain (IL4R) coordinates IL-4 and IL-13 signalling and sits at the heart of type 2 immune responses studied in allergy and atopic disease. This anti-human IL4R recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of stapokibart, provided for research use only. Manufactured under stringent in vivo standards with a low-endotoxin formulation, it is supplied in scalable milligram (mg) to gram (g) quantities to serve bulk and high-throughput laboratories. It is well suited to receptor-blockade assays, in vitro functional screening, and in vivo models of allergic and inflammatory disease.
Specificity
Detects human IL4R
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
4 weeks
Write Your Own Review


















